These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 32463914

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I, Bezchlibnyk-Butler K, Wong L.
    Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
    [Abstract] [Full Text] [Related]

  • 3. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW, Bogers JP, Giltay EJ.
    Gen Hosp Psychiatry; 2013 Jun; 35(5):576.e11-2. PubMed ID: 23395419
    [Abstract] [Full Text] [Related]

  • 4. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N, Myles H, Clark SR, Bird R, Siskind D.
    Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
    Kolli V, Denton K, Borra D, Pulluri M, Sharma A.
    Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Successful treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor.
    Raison CL, Guze BH, Kissell RL.
    J Clin Psychopharmacol; 1994 Aug; 14(4):285-6. PubMed ID: 7525662
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clozapine-induced agranulocytosis: a case report. Immunopathophysiological considerations.
    van de Loosdrecht AA, Faber HJ, Hordijk P, Uges DR, Smit A.
    Neth J Med; 1998 Jan; 52(1):26-9. PubMed ID: 9573739
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association between clozapine-induced agranulocytosis and HLA subtyping.
    Lopez-Garcia P, Teresa Rodriguez J, De Castro P, Landecho I, Zapata R.
    J Clin Psychiatry; 2006 Oct; 67(10):1652-3. PubMed ID: 17107265
    [No Abstract] [Full Text] [Related]

  • 18. Olanzapine: safe during clozapine-induced agranulocytosis.
    Oyewumi LK, Al-Semaan Y.
    J Clin Psychopharmacol; 2000 Apr; 20(2):279-81. PubMed ID: 10770478
    [No Abstract] [Full Text] [Related]

  • 19. Failure of rechallenge clozapine after agranulocytosis: A case report.
    Roméo B, Petillion A, Martelli C, Benyamina A.
    Encephale; 2019 Nov; 45(5):449-450. PubMed ID: 30878138
    [No Abstract] [Full Text] [Related]

  • 20. A case of clozapine induced agranulocytosis 25 years after starting treatment: Effective use of lithium for augmentation in rechallenge.
    Martina AC, Ee JS, Lamberti JS.
    Schizophr Res; 2019 Aug; 210():308-309. PubMed ID: 31277977
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.